he performance of meaningful computational research depends on the availability of suicient data for analysis. Indeed, the analysis of isolates from the current Ebola outbreak in West Africa resulted in a steep increase in sequencing data [2-8] that enable computational investigation.
he recent Ebola outbreak in Western Africa taught us that Ebolaviruses can cause much larger outbreaks and represent a much greater health threat than many of us believed (or wanted to believe). As of 30 th March, the outbreak had resulted in 28,646 conirmed cases and 11,323 deaths. Although the WHO stated that the Ebola epidemic in West Africa no longer represents a Public Health Emergency of International Concern, since Guinea, Liberia, and Sierra are now capable of controlling and maintaining further small outbreaks, lare-ups still occur, most recently, on 4 th April when two new cases were reported in Liberia (www.who.int).
Our understanding of the Ebolavirus biology remains limited. A major reason for this is that Ebolaviruses are safety level 4 pathogens and that there is only a very limited number of appropriate containment level laboratories. Computational studies were suggested as a strategy to increase research on Ebolaviruses and to complement wet laboratory, clinical, and epidemiological studies. he International Society of Computational Biology (ISCB) acknowledged this and launched an award for computational biology studies on Ebola [1] .
he performance of meaningful computational research depends on the availability of suicient data for analysis. Indeed, the analysis of isolates from the current Ebola outbreak in West Africa resulted in a steep increase in sequencing data [2] [3] [4] [5] [6] [7] [8] that enable computational investigation.
A number of computational studies have already made use of these data in order to gain novel insights into the Ebolavirus biology. Two studies used similar bioinformatics approaches to identify potential microRNAs [9, 10] . Further, two studies determined speciic signatures as potential vaccine, diagnostic, or therapeutic targets [11, 12] . Wet laboratory experiments will now be needed to validate these computational predictions.
he need for a close interaction between computational and wet laboratories is particularly emphasised by two recent studies that investigated the diferencesin human pathogenicity between the Ebolavirus species. he two studies used similar approaches but came to diferent results [13, 14] . Both studies compared the genomes of the four human pathogenic Ebolavirus species Zaire ebolavirus (type virus: Ebola virus), Sudan ebolavirus (type virus: Sudan virus), Bundibugyo ebolavirus (type virus: Bundibugyo virus), and Tai Forest ebolavirus (type virus: Tai Forest virus) to the available genomes of the Reston virus (species Reston ebolavirus) [13, 14] that causes disease in primates but not in humans [15] .
In order to identify variations that may cause the diferences in human pathogenicity, Cong et al. [13] identiied positions in Ebolavirus proteins that are diferently conserved between human-pathogenic Ebolaviruses and Reston viruses. hey could map 43 out of 215 diferentially conserved positions onto structures or models of Ebolavirus proteins. his information was combined with ananalysis of the variations between human and primate host cell proteins that are known to interact with Ebolavirus proteins. he authors found diferences in the Ebolavirus VP24 protein that may afect the interaction of VP24 and KPNA5 and in turn the VP24-mediated inhibition of STAT1 activation and interferon signalling. However, they concluded that diferences in VP24, VP30, and VP40 are unlikely to be responsible for the diferences in human pathogenicity because the host proteins that interact with these virus proteins are very similar. he host interaction partners of GP and VP35 displayed greater variability, and Cong et al. [13] thus, suggested that a cluster of diferentially conserved residues in the C terminal region of GP and a cluster of changes in VP35 may cause the diferences in human pathogenicity between the Ebolavirus species.
In the second study, we identiied speciicity determining positions (SDPs) [16] to identify positions that are diferentially conserved between the sequences of human pathogenic Ebolaviruses and Reston viruses [14] . 47 out of 189 SDPs could be modelled onto protein structuresor models (generated using Phyre2 [17, 18] ) resulting in eight SDPs that potentially modify protein stability (2) or protein-protein interactions (6) [14] . Four of these SDPs occurred in VP24 with three of them being locatedin the VP24-KPNA5 binding site. A comparison of the three SDPs in the VP24-KPNA5 binding site with Ebola virus VP24 residues that when mutated are known to decrease VP24 binding to KPNA5 and in turn to impair the capacity of Ebola virus VP24 to inhibit interferon signalling, suggestedthat Reston virus VP24 is less efective in antagonising the interferon response in human cells than Ebola virus VP24. If this interpretation is correct, few mutations in VP24 may result in a human pathogenic Reston virus. Hence, our predictions difer substantially from those of Cong et al. [13, 14] .
In conclusion, computational studies can provide novel insights into the biology of safety level 4 pathogens like Ebolaviruses for which wet lab research is limited to a small number of high containment laboratories. However, to achieve their full potential computational approaches require exchange with wet laboratory researchers. Only if wet laboratory scientists take computational predictions into accountwhen planning their experiments and report their indings, computational researchers will be able to improve the predictive power and accuracy of their methods in an iterative approach. Whether this will happen will depend on the openmindedness, tolerance, patience, curiosity, and preparedness to leave the comfort zone on both sides. Nevertheless, we are convinced that this is worth the efort because it will enable us as research community to make optimal use of all available resources.
